Takayo Ota

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Interstitial Lung Disease

Neoadjuvant Chemotherapy

Tyrosine Kinase

Top Venues

Surgical case reports

Respirology case reports

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Takayo Ota, Katsuya Sakashita, Ryugo Sawada, Kurumi Seki, Hiroyuki Maeda, Noriko Tanaka, Toshimasa Tsujinaka
Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature. Surgical case reports 9 (1) (2023)
Takayo Ota, Katsuya Sakashita, Ryugo Sawada, Kurumi Seki, Hiroyuki Maeda, Noriko Tanaka, Toshimasa Tsujinaka
Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature. Surgical case reports 9 (1) (2023)
Rei Noguchi, Akihiro Yoshimura, Uchino Junji, Takayuki Takeda, Yusuke Chihara, Takayo Ota, Osamu Hiranuma, Hiroshi Gyotoku, Takayama Koichi, Tadashi Kondo
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations. Proteomes 11 (1) (2023)
Takayo Ota, Katsuya Sakashita, Ryugo Sawada, Kurumi Seki, Hiroyuki Maeda, Noriko Tanaka, Toshimasa Tsujinaka
Long-term survival with nivolumab followed by irinotecan after total gastrectomy in alpha-fetoprotein-producing gastric cancer: a case report and review of the literature. Surgical case reports 9 (1) (2023)
Rei Noguchi, Akihiro Yoshimura, Uchino Junji, Takayuki Takeda, Yusuke Chihara, Takayo Ota, Osamu Hiranuma, Hiroshi Gyotoku, Takayama Koichi, Tadashi Kondo
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations. Proteomes 11 (1) (2023)
Takayo Ota, Aya Okabayashi, Masahiro Fukuoka
Rapid and dramatic responses to dabrafenib and trametinib in BRAF V600E-mutated lung adenocarcinoma. Respirology case reports 9 (10) (2021)
Kenji Tezuka, Kotaro Miura, Yusuke Nakano, Takahiro Ueda, Kyoko Yagyu, Shimako Matsuyama, Masami Shirai, Hiroshi Okuda, Miho Ujikawa, Takayo Ota
Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer. World journal of surgical oncology 19 (1) (2021)
Takayo Ota, Tomoya Fukui, Yoshiro Nakahara, Takayuki Takeda, Junji Uchino, Takako Mouri, Keita Kudo, Saki Nakajima, Tomohiro Suzumura, Masahiro Fukuoka
Serum immune modulators during the first cycle of anti-PD-1 antibody therapy in non-small cell lung cancer: Perforin as a biomarker. Thoracic cancer 11 (11) (2020)
Takayo Ota, Yoshikazu Hasegawa, Takafumi Okabe, Akira Okimura, Masahiro Fukuoka
Porous diaphragm syndrome with recurrent thymoma. Respirology case reports 7 (2) (2018)
Takayo Ota, Yoshikazu Hasegawa, Akira Okimura, Katsuya Sakashita, Takeshi Sunami, Kiyotaka Yukimoto, Ryugo Sawada, Kazutsugu Sakamoto, Masahiro Fukuoka
Breast metastasis from EGFR-mutated lung adenocarcinoma: A case report and review of the literature. Clinical case reports 6 (8) (2018)